GLAXOSMITHKLINE PHARMACEUTICALS
Back to Income Statement
|
GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Total Expenditure History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Expenditure | ₹2,545 Cr | ₹2,447 Cr | ₹2,516 Cr | ₹2,327 Cr | ₹2,567 Cr |
What is the latest Total Expenditure of GLAXOSMITHKLINE PHARMACEUTICALS ?
| Year | Total Expenditure |
|---|---|
| Mar2025 | ₹2,545 Cr |
| Mar2024 | ₹2,447 Cr |
| Mar2023 | ₹2,516 Cr |
| Mar2022 | ₹2,327 Cr |
| Mar2021 | ₹2,567 Cr |
How is Total Expenditure of GLAXOSMITHKLINE PHARMACEUTICALS Trending?
| Years | Total Expenditure | % Change | |
|---|---|---|---|
| Mar2025 | ₹2,545 Cr | 3.99 | |
| Mar2024 | ₹2,447 Cr | -2.73 | |
| Mar2023 | ₹2,516 Cr | 8.11 | |
| Mar2022 | ₹2,327 Cr | -9.34 | |
| Mar2021 | ₹2,567 Cr | - | |
Compare Total Expenditure of peers of GLAXOSMITHKLINE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAXOSMITHKLINE PHARMACEUTICALS | ₹42,958.1 Cr | -3.2% | 5.3% | -2.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹420,531.0 Cr | 1.3% | 8.9% | 6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹169,989.0 Cr | 2.4% | 6% | 12.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹147,936.0 Cr | -0.6% | 9.4% | 44.1% | Stock Analytics | |
| CIPLA | ₹109,200.0 Cr | 1.9% | 2% | -8.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,057.0 Cr | -0.4% | 9.5% | 10.5% | Stock Analytics | |
GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAXOSMITHKLINE PHARMACEUTICALS | -3.2% |
5.3% |
-2.3% |
| SENSEX | -3.7% |
-2.5% |
6.5% |
You may also like the below Video Courses